Diffuse hair loss in women in Ahwaz

author

  • ZB Mousavi
Abstract:

Background: Diffuse hair loss is one of the most common complaints of women attending skin clinics. Objective: The purpose of this study was to evaluate diffuse hair loss in women referring to a private office. Patients and Methods: This descriptive, retrospective study was performed on women attending a private skin clinic in Ahwaz complaining of diffuse hair loss. The study was done for 10 months in 1376-77. The patients who were hirsute or had apparent clinical pattern of androgenetic or scarring alopecia were excluded. Results: 68% of the total of 180 patients aged between 10 to 30 years old. Thyroid function disorders was found in 18.8%, and anemia was the only finding in 23% of the patients. Trichotillomania was observed in 3.2% and in 41.4% we could not find any clinical or laboratory positive finding. Conclusion: Women complaining of diffuse hair loss should be screened for thyroid disorders and anemia.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Iron status in diffuse telogen hair loss among women.

The relationship between iron body status and different types of hair loss has been investigated in a number of studies, however, with relatively discrepant findings. Therefore we conducted an analytical case-control study to assess whether diffuse telogen hair loss in women of childbearing age (15 to 45 years old) is associated with iron deficiency. Using the analytical case-control methodolog...

full text

Hair Loss in Women

From the Department of Dermatology and Skin Science, University of British Columbia, and Vancouver Coastal Health Research Institute — both in Vancouver, Canada; and the Department of Dermatology, New York University, New York. Address reprint requests to Dr. Shapiro at the Department of Dermatology and Skin Science, University of British Columbia, 835 W. 10th Ave., Vancouver, BC V5Z 4E8, Canada.

full text

Diffuse Hair Loss Induced by Sertraline Use

Hair loss is a rare side effect of psychotropic drugs. The most related drug class with this side effect is the mood stabilizers. Studies reporting the sertraline-induced alopecia are limited in number. Sertraline is a potent antidepressant which inhibits the serotonin reuptake from the presynaptic terminals selectively. The reason for hair loss could not be elucidated completely. Psychotropic ...

full text

Diffuse hair loss: its triggers and management.

Diffuse hair loss can affect both sexes at any age. Anything that interrupts the normal hair cycle can trigger diffuse hair loss. Triggers include a wide variety of physiologic or emotional stresses, nutritional deficiencies, and endocrine imbalances. Loss of telogen-phase hairs is the most common. Hair loss during the anagen phase is usually caused by chemotherapy or radiation therapy. Finding...

full text

Hair loss and hyperprolactinemia in women

In the literature of the past 30 years there are only some publications concerned with hair loss and hyperprolactinemia in women. Therefore, the relevance of hyperprolactinemia was evaluated in 40 women with diffuse alopecia.Hair loss was assessed by clinical appearance and the pluck trichogram. 82.5% of the female patients had diffuse hair loss and 17.5% had androgenetic alopecia.The highest p...

full text

The convergence between diagnostic methods in women with non-scarring hair loss

Background: Hair loss is a major cause of dermatology visits resulting in considerable anxiety and distress for patients. The objective of the current research was to investigate the association among various diagnostic methods related to non-scarring hair loss in women.Methods: After obtaining the complete history, clinical examination was carried out on women suffering from diffuse nonscaring...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 2  issue 4

pages  12- 16

publication date 1999-08-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023